FMTO
Femto Technologies Inc. Common StockFMTO
FMTO
About: Femto Technologies Inc is an integrated software company. It owns and markets Benefit CRM, a proprietary customer relationship management CRM software product enabling small and medium sized businesses to optimize their day to day business activities such as sales management, personnel management, marketing, call center activities, and asset management.
Employees: 6
0
Funds holding %
of 7,296 funds
–
Analysts bullish %
Fund manager confidence
Based on 2025 Q1 regulatory disclosures by fund managers ($100M+ AUM)
2,671% more capital invested
Capital invested by funds: $5.89K [Q4 2024] → $163K (+$157K) [Q1 2025]
200% more first-time investments, than exits
New positions opened: 6 | Existing positions closed: 2
133% more funds holding
Funds holding: 3 [Q4 2024] → 7 (+4) [Q1 2025]
20.12% more ownership
Funds ownership: 0.11% [Q4 2024] → 20.23% (+20.12%) [Q1 2025]
Research analyst outlook
We haven’t received any recent analyst ratings for FMTO.
Financial journalist opinion
Neutral
TheNewswire
1 month ago
Femto Technologies Announces First Quarter 2025 Financial Results
Vancouver, BC – May 15, 2025 – TheNewswire – Femto Technologies Inc. (Nasdaq: FMTO ) (“ Femto ” or the “ Company ”), a pioneering femtech company has released its financial results for three-month ended March 31, 2025. Full versions of Femto's unaudited consolidated interim financial statements and management discussion and analysis for the period, can be found on www.sedarplus.ca . Q1 2025 Financial and Business Highlights:
Neutral
TheNewswire
1 month ago
Femto Technologies Inc. Announces Stock Repurchase Program
Vancouver, BC – May 15, 2025 – TheNewswire - Femto Technologies Inc. (Nasdaq: FMTO) (the “ Company ” or “ Femto ”), a pioneering femtech company, announce s that its Board of Directors has authorized a stock repurchase program (the “ Stock Repurchase Program ”) to repurchase up to 43,025 subordinate voting shares of the Company (the “ Subordinate Voting Shares ”), representing up to 5% of the issued and outstanding Subordinate Voting Shares as at the close of business on May 14, 2025. The Stock Repurchase Program will commence on May 20, 2025, and is expected to last for up to six months. The Stock Repurchase Program does not obligate the Company to repurchase any dollar amount or number of shares, and the program may be extended, modified, suspended or discontinued at any time. “Our stock repurchase authorization reflects the Board's decision to support the company's capital and increase shareholder value and return,” said Yftah Ben Yaackov, Chief Executive Officer. “We are confident in our ability to generate increasing amounts of free cash flow and are committed to continue to strategically deploy capital where we believe it can generate stockholder value.”
Neutral
TheNewswire
1 month ago
U.S. Patent and Trademark Office Granted Femto Technologies Inc. A Notice of Allowance for Use of its Sensera design
Nasdaq-Listed Femtech Innovator, creator of Sensera, Advances AI-Driven Feminine Wellness Solutions Los Angeles, California – May 13, 2025 – TheNewswire - Femto Technologies Inc. (Nasdaq: FMTO), a pioneering Femtech company formerly known as BYND Cannasoft Enterprises Inc., announced today that the U.S. Patent and Trademark Office (USPTO) has granted it a Notice of Allowance for its female treatment device – sensera design. This milestone reinforces Femto's commitment to redefining wellness solutions through AI-driven advancements.
Neutral
TheNewswire
1 month ago
Femto Technologies, Creator of Sensera, to Present at Aegis Capital Financial Conference
New York – TheNewswire - May 12th, 2025 – Femto Technologies Inc. (Nasdaq: FMTO )(“ Femto ” or the “ Company ”), the pioneering AI innovator and recent CES Award winner for its cutting-edge SRS feminine wellness technology, is set to present at the upcoming Aegis Capital Financial Conference to be held on May 20-22, 2025. In the event, recognized for convening top-tier investors and industry leaders, Femto will showcase its latest advancements in harnessing artificial intelligence in the feminine wellness sector as well as biofeedback sensor-driven analytics. The Aegis Capital Financial Conference is a key forum, connecting industry experts, investors, and stakeholders interested in emerging technologies with transformative potential. It will be facilitated virtually and in person in New York City and hosted by Aegis Capital Corp., a premier full-service investment entity dedicated to delivering personalized financial wealth management and investment banking services. Operating since 1984, Aegis is dedicated to providing corporate finance, strategic advisory and related services to public and private companies across multiple sectors and regions. It also provides research, sales and trading services to institutional and retail investors, while offering its investment representatives a conflict free service platform that enables a full-range of products and services including investment banking, wealth management, insurance, retirement planning, structured products, private equity, alternatives, equity research, fixed income and special purpose vehicles.
Neutral
TheNewswire
1 month ago
FEMTO Receives Nasdaq Delisting Determination and Plans to Appeal
May 9, 2025 – TheNewswire - Femto Technologies Inc. (Nasdaq: FMTO), a pioneering Femtech company formerly known as BYND Cannasoft Enterprises Inc., announced today that it has received on May 8, 2025 a notification letter from The Nasdaq Stock Market LLC (“Nasdaq”), stating that based on its review of the Company's recent private placement transaction that was completed on February 26, 2025 (the “Placement”), Nasdaq has determined to delist the Company's securities pursuant to its discretionary authority under Listing Rule 5101. As set forth in its letter, Nasdaq's staff (the “Staff”) determined that the Company's issuance of large numbers of shares upon the cashless exercise and “alternative exercise” of the Warrants issued in the Placement resulted in significant dilution of existing shareholders thereby triggering the Staff's determination.
Neutral
TheNewswire
1 month ago
U.S. Patent and Trademark Office Granted Femto Technologies Inc. a Notice of Allowance for Use of its Proprietary Smart Release System Technology
Nasdaq-Listed Femtech Innovator, creator of Sensera, Advances AI-Driven Feminine Wellness Solution s Los Angeles, California – TheNewswire - May 7, 2025 – Femto Technologies Inc. (Nasdaq: FMTO), a pioneering Femtech company formerly known as BYND Cannasoft Enterprises Inc., announced today that the U.S. Patent and Trademark Office (USPTO) has granted it a Notice of Allowance for its proprietary Smart Release System (SRS) technology. This milestone reinforces Femto's commitment to redefining wellness solutions through AI-driven advancements.
Neutral
TheNewswire
1 month ago
Femto Technologies Announces Reverse Split Implemented
The reverse stock split is part of the Company's plan to regain compliance with the minimum bid price requirement for continued listing on The Nasdaq Capital Market April 22, 2025 – TheNewswire – Femto Technologies Inc. (Nasdaq: FMTO ) (“ Femto ” or the “ Company ”), a FemTech pioneer and the creator of Sensera, a feminine wellness product, has today announced that the previously announced 1-for-500 reverse stock split of its outstanding subordinate voting shares has been made effective today, April 22, 2025. This reverse split was approved by the board of directors of the Company on April 10, 2025.
Neutral
TheNewswire
1 month ago
Femto Technologies Announces Reverse Split
The reverse stock split is part of the Company's plan to regain compliance with the minimum bid price requirement for continued listing on The Nasdaq Capital Market
Neutral
TheNewswire
2 months ago
Femto Technologies Inc. Announces Results of AGM
Vancouver, BC - (April 2, 2025) – TheNewswire - Femto Technologies Inc. (Nasdaq: ( FMTO ) (“ Femto ” or the “ Company ”), a FemTech pioneer and the creator of Sensera, a feminine wellness product, is pleased to announce the results of its annual general meeting of shareholders (the “ AGM ”) held today. Shareholders approved all matters recommended by management, including: setting the number of directors at five and electing Yftah Ben Yaacov, Gabi Kabazo, Harold Wolkin, Stefania Szabo and Carmel Zigdon as directors of the Company;
Neutral
TheNewswire
3 months ago
Femto Technologies Inc. Announces Closing of $17 Million Private Placement
ASHKELON, ISRAEL AND VANCOUVER, BRITISH COLUMBIA – TheNewswire - FEBRUARY 28, 2025 - Femto Technologies Inc. (Nasdaq: FMTO ) (“ Femto ” or the “ Company ”), a FemTech pioneer and the creator of Sensera , a feminine wellness product, today announced the closing of its previously announced private placement of approximately $17 million of Common Shares (also known as Subordinate Voting Shares under British Columbia corporation law) and pre-funded and investor warrants at a price of $4.17 per Common Unit. The offering consisted of the sale of 4,076,736 Common Units (or Pre-Funded Units), each consisting of (i) one Common Share or Pre-Funded Warrant, (ii) one Series A Warrant to purchase one Common Share per warrant and (iii) one Series B Warrant to purchase one Common Share per warrant. The offering price per Common Unit was $4.17 (or $4.16999 for each Pre-Funded Unit, which is equal to the offering price per Common Unit sold in the offering minus an exercise price of $0.00001 per Pre-Funded Warrant). The Pre-Funded Warrants are immediately exercisable and may be exercised at any time. The initial exercise price of each Series A Warrant is $5.21 per Common Share. The Series A Warrants are exercisable immediately and have a term of 60 months. The number of securities issuable under the Series A Warrants is subject to adjustment as described in more detail in the report on Form 6-K filed in connection with the offering. The initial exercise price of each Series B Warrant is $12.51 per Common Share or pursuant to an alternative cashless exercise option. The Series B Warrants are immediately exercisable and have a term of 30 months. The number of securities issuable under the Series B Warrants is subject to adjustment as described in more detail in the report on Form 6-K filed in connection with the offering.
Charts implemented using Lightweight Charts™